A rare, aggressive variant of intrahepatic cholangiocarcinoma. It is characterized by the presence of adenocarcinoma cells that are intermingled with malignant pleomorphic spindle cells.
Comprehensive, easy-to-understand information about this condition
How we create this content →Report Generation Failed
We couldn't automatically generate the report. This may be due to temporary service issues.
Organizations with approved therapies for this disease
No approved therapies yet
Research is ongoing — 3 companies have orphan drug designations for this disease
Kisho delivers this disease record via API, including phenotypes (HPO), genes, orphan drug designations, screening status, and PAG mapping, with version history and governance.
AI-curated news mentioning sarcomatous intrahepatic cholangiocarcinoma
Updated Feb 5, 2026
A narrative review discusses the surgical management of intrahepatic cholangiocarcinoma and combined hepatocellular-cholangiocarcinoma, highlighting principles, technical nuances, and emerging strategies. This review provides insights into evolving surgical techniques that may improve patient outcomes.